Literature DB >> 15486094

Brain region-dependent effects of dexamethasone on counterregulatory responses to hypoglycemia in conscious rats.

Darleen A Sandoval1, Ling Ping, Ray Anthony Neill, Bin Gong, Kristen Walsh, Stephen N Davis.   

Abstract

The aim of this study was to determine whether activation of central type II glucocorticoid receptors can blunt autonomic nervous system counterregulatory responses to subsequent hypoglycemia. Sixty conscious unrestrained Sprague-Dawley rats were studied during 2-day experiments. Day 1 consisted of either two episodes of clamped 2-h hyperinsulinemic (30 pmol x kg(-1) x min(-1)) hypoglycemia (2.8 +/- 0.1 mM; n = 12), hyperinsulinemic euglycemia (6.2 +/- 0.1 mM; n = 12), hyperinsulinemic euglycemia plus simultaneous lateral cerebroventricular infusion of saline (24 microl/h; n = 8), or hyperinsulinemic euglycemia plus either lateral cerebral ventricular infusion (n = 8; LV-DEX group), fourth cerebral ventricular (n = 10; 4V-DEX group), or peripheral (n = 10; P-DEX group) infusion of dexamethasone (5 microg/h), a specific type II glucocorticoid receptor analog. For all groups, day 2 consisted of a 2-h hyperinsulinemic (30 pmol x kg(-1) x min(-1)) or hypoglycemic (2.9 +/- 0.2 mM) clamp. The hypoglycemic group had blunted epinephrine, glucagon, and endogenous glucose production in response to subsequent hypoglycemia. Consequently, the glucose infusion rate to maintain the glucose levels was significantly greater in this group vs. all other groups. The LV-DEX group did not have blunted counterregulatory responses to subsequent hypoglycemia, but the P-DEX and 4V-DEX groups had significantly lower epinephrine and norepinephrine responses to hypoglycemia compared with all other groups. In summary, peripheral and fourth cerebral ventricular but not lateral cerebral ventricular infusion of dexamethasone led to significant blunting of autonomic counterregulatory responses to subsequent hypoglycemia. These data suggest that prior activation of type II glucocorticoid receptors within the hindbrain plays a major role in blunting autonomic nervous system counterregulatory responses to subsequent hypoglycemia in the conscious rat.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486094     DOI: 10.1152/ajpregu.00674.2003

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  6 in total

1.  Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference.

Authors:  Oleg Otlivanchik; Nicole M Sanders; Ambrose Dunn-Meynell; Barry E Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-28       Impact factor: 3.619

2.  Antecedent hindbrain glucoprivation does not impair the counterregulatory response to hypoglycemia.

Authors:  Nicole M Sanders; Gerald J Taborsky; Charles W Wilkinson; Wendi Daumen; Dianne P Figlewicz
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

3.  Forebrain and hindbrain effects of ethanol on counterregulatory responses to hypoglycemia in conscious rats.

Authors:  Darleen A Sandoval; Bin Gong; Stephen N Davis
Journal:  Metabolism       Date:  2007-12       Impact factor: 8.694

4.  The role of GM-CSF in adipose tissue inflammation.

Authors:  Dong-Hoon Kim; Darleen Sandoval; Jacquelyn A Reed; Emily K Matter; Emeline G Tolod; Stephen C Woods; Randy J Seeley
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-02       Impact factor: 4.310

5.  Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake.

Authors:  Darleen A Sandoval; Didier Bagnol; Stephen C Woods; David A D'Alessio; Randy J Seeley
Journal:  Diabetes       Date:  2008-05-16       Impact factor: 9.461

6.  Hypothalamic Vitamin D Improves Glucose Homeostasis and Reduces Weight.

Authors:  Stephanie R Sisley; Deanna M Arble; Adam P Chambers; Ruth Gutierrez-Aguilar; Yanlin He; Yong Xu; David Gardner; David D Moore; Randy J Seeley; Darleen A Sandoval
Journal:  Diabetes       Date:  2016-05-23       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.